Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Leases (2019 - 2025)

Historic Current Leases for Tandem Diabetes Care (TNDM) over the last 7 years, with Q3 2025 value amounting to $21.3 million.

  • Tandem Diabetes Care's Current Leases rose 1834.41% to $21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.3 million, marking a year-over-year increase of 1834.41%. This contributed to the annual value of $18.2 million for FY2024, which is 672.92% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Current Leases is $21.3 million, which was up 1834.41% from $19.9 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Current Leases registered a high of $21.3 million during Q3 2025, and its lowest value of $8.1 million during Q1 2022.
  • Moreover, its 5-year median value for Current Leases was $17.1 million (2023), whereas its average is $14.8 million.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 1446.11% in 2022, then surged by 9615.1% in 2023.
  • Tandem Diabetes Care's Current Leases (Quarter) stood at $9.3 million in 2021, then soared by 41.41% to $13.1 million in 2022, then skyrocketed by 30.02% to $17.1 million in 2023, then increased by 6.73% to $18.2 million in 2024, then increased by 17.21% to $21.3 million in 2025.
  • Its last three reported values are $21.3 million in Q3 2025, $19.9 million for Q2 2025, and $20.7 million during Q1 2025.